Prospective analysis of 30-day mortality following palliative chemotherapy at a tertiary cancer centre.

Background: Thirty-day mortality after chemotherapy has been suggested as a marker of quality in oncology care. Retrospective audits worldwide have put this figure at between 8.1% and 43%, with previous retrospective Australian audits putting this figure at between 3.